CA3116730C - Compositions d'epinephrine sublinguales comprenant des excipients modifiant le ph et des amplificateurs de la penetration et leurs methodes d'utilisation - Google Patents

Compositions d'epinephrine sublinguales comprenant des excipients modifiant le ph et des amplificateurs de la penetration et leurs methodes d'utilisation

Info

Publication number
CA3116730C
CA3116730C CA3116730A CA3116730A CA3116730C CA 3116730 C CA3116730 C CA 3116730C CA 3116730 A CA3116730 A CA 3116730A CA 3116730 A CA3116730 A CA 3116730A CA 3116730 C CA3116730 C CA 3116730C
Authority
CA
Canada
Prior art keywords
epinephrine
sublingual
sds
fine particles
epi
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA3116730A
Other languages
English (en)
Other versions
CA3116730A1 (fr
Inventor
Mutasem Rawas-Qalaji
Original Assignee
Nova Southeastern University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nova Southeastern University filed Critical Nova Southeastern University
Priority claimed from PCT/US2019/056967 external-priority patent/WO2020081952A1/fr
Publication of CA3116730A1 publication Critical patent/CA3116730A1/fr
Application granted granted Critical
Publication of CA3116730C publication Critical patent/CA3116730C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

L'invention concerne des compositions d'épinéphrine sublinguales qui comprennent des particules fines d'épinéphrine formulées avec des excipients modifiant le pH et des amplificateurs de la pénétration. Les compositions sublinguales sont utilisées pour réguler l'absorption d'épinéphrine au niveau du site d'administration dans la cavité buccale. L'invention concerne également des méthodes d'utilisation thérapeutique des compositions sublinguales pour le traitement d'affections sensibles à l'épinéphrine et/ou pour augmenter la biodisponibilité sublinguale de l'épinéphrine.
CA3116730A 2018-10-19 2019-10-18 Compositions d'epinephrine sublinguales comprenant des excipients modifiant le ph et des amplificateurs de la penetration et leurs methodes d'utilisation Active CA3116730C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862748117P 2018-10-19 2018-10-19
US62/748,117 2018-10-19
PCT/US2019/056967 WO2020081952A1 (fr) 2018-10-19 2019-10-18 Compositions d'épinéphrine sublinguales comprenant des excipients modifiant le ph et des amplificateurs de la pénétration et leurs méthodes d'utilisation

Publications (2)

Publication Number Publication Date
CA3116730A1 CA3116730A1 (fr) 2020-04-23
CA3116730C true CA3116730C (fr) 2026-02-24

Family

ID=

Similar Documents

Publication Publication Date Title
US20260007619A1 (en) Sublingual Epinephrine Compositions Including pH-Modifying Excipients And Penetration Enhancers And Methods for Use Thereof
US20220218629A1 (en) Epinephrine fine particles and methods for use thereof
US10568836B2 (en) Epinephrine nanoparticles encapsulated with chitosan and tripolyphosphate, methods of fabrication thereof, and methods for use thereof for treatment of conditions responsive to epinephrine
RU2436565C2 (ru) Распадающиеся пероральные пленки
ES2660116T3 (es) Dispositivos mucoadhesivos resistentes al uso inadecuado para la administración de buprenorfina
US20240252470A1 (en) Use of sublingual dexmedetomidine for the treatment of agitation
US10159656B2 (en) Methods for use of epinephrine fine particles for treatment of conditions responsive to epinephrine
US9877921B2 (en) Epinephrine nanoparticles, methods of fabrication thereof, and methods for use thereof for treatment of conditions responsive to epinephrine
US20230248660A1 (en) Method of preparing loxapine film oral dosage form
US9326935B2 (en) Atomoxetine solution
CN110418639A (zh) 肾上腺素舌下或口含给药制剂
JP2023506545A (ja) アゴメラチンを含有する経粘膜治療システム
KR20010093256A (ko) 개선된 안정성을 갖는 조성물
ES2738652T3 (es) Composiciones de midazolam para administración bucal en el tratamiento de convulsiones para obtener comienzo de acción rápido
CN115529815B (zh) 经直肠施用的奥司他韦或其药学上可接受的盐的药物组合物、及其制备方法和用途
RU2625766C1 (ru) Средство для экстренного восстановления голоса при внезапной афонии
FR3123803A3 (fr) Mélange gazeux utilisable en cas d’accident vasculaire cérébral ischémique